# PeptideScanner evidence objects: Selank

Every published version of the records placed with Selank, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/selank.json. Selected public evidence only; not medical advice.

- Objects: 13
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="pubmed-pmid-15508574-selank-v1"></a>

## A new property of the synthetic anxiolytic Selank and its derivatives.

> PubMed lists PMID 15508574 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-15508574-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-16
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-15508574-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-15508574-selank-v1
- Content SHA-256: `effbbaae06696f969e8ff2e5015490c12f1599c31c1d648f814fedd4eb191db0`

### Claims and source pins

#### Headline

A new property of the synthetic anxiolytic Selank and its derivatives. ([`pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b`](#source-pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b))

#### Summary

PubMed lists PMID 15508574 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b`](#source-pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b))

#### Paragraph 1

PubMed lists PMID 15508574 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004 Jul-Aug (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b`](#source-pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b`](#source-pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b))

### Sources

<a id="source-pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b"></a>
- **A new property of the synthetic anxiolytic Selank and its derivatives. · retained source version 1:2026-10-16:current:5b634629ab1b75498b62da82dbe300d9b98ce6b2c7c2ce739afc75d03bde1a61** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/15508574/) (`pubmed-observation-pmid-15508574-2026-10-16-5b634629ab1b`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "A new property of the synthetic anxiolytic Selank and its derivatives." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-15508574-selank-v1 SHA-256: effbbaae06696f969e8ff2e5015490c12f1599c31c1d648f814fedd4eb191db0.

---

<a id="pubmed-pmid-18019011-selank-v1"></a>

## Selank and its metabolites maintain homeostasis in the gastric mucosa.

> PubMed lists PMID 18019011 in Bulletin of experimental biology and medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-01 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-18019011-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-08-13
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-18019011-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-18019011-selank-v1
- Content SHA-256: `0679c94c8ca908eba2e9102461cb8b556669ced06f2c927800c61827bd967b18`

### Claims and source pins

#### Headline

Selank and its metabolites maintain homeostasis in the gastric mucosa. ([`pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94`](#source-pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94))

#### Summary

PubMed lists PMID 18019011 in Bulletin of experimental biology and medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-01 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94`](#source-pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94))

#### Paragraph 1

PubMed lists PMID 18019011 in Bulletin of experimental biology and medicine as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-01 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94`](#source-pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94`](#source-pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94))

### Sources

<a id="source-pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94"></a>
- **Selank and its metabolites maintain homeostasis in the gastric mucosa. · retained source version 1:2019-08-13:current:3caef2596e947d7f78337c1432f1918b9d9d01c86e58df4e990d430579a6d19a** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/18019011/) (`pubmed-observation-pmid-18019011-2019-08-13-3caef2596e94`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Selank and its metabolites maintain homeostasis in the gastric mucosa." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-18019011-selank-v1 SHA-256: 0679c94c8ca908eba2e9102461cb8b556669ced06f2c927800c61827bd967b18.

---

<a id="pubmed-pmid-18197389-selank-v1"></a>

## Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia.

> PubMed lists PMID 18197389 in Neuroscience and behavioral physiology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-02 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-18197389-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-11
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-18197389-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-18197389-selank-v1
- Content SHA-256: `17844849bdde87aa8c23a37c952237500e1603df58383eba3483678366af49ac`

### Claims and source pins

#### Headline

Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia. ([`pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9`](#source-pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9))

#### Summary

PubMed lists PMID 18197389 in Neuroscience and behavioral physiology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-02 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9`](#source-pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9))

#### Paragraph 1

PubMed lists PMID 18197389 in Neuroscience and behavioral physiology as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008-02 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9`](#source-pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9`](#source-pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9))

### Sources

<a id="source-pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9"></a>
- **Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia. · retained source version 1:2026-10-11:current:e4ad67369fb9f41a808f4916024416cbf631e747b2967bb4c67fad347364f55d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/18197389/) (`pubmed-observation-pmid-18197389-2026-10-11-e4ad67369fb9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Use of Selank to correct measures of integrative brain activity and biogenic amine levels in adult rats resulting from antenatal hypoxia." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-18197389-selank-v1 SHA-256: 17844849bdde87aa8c23a37c952237500e1603df58383eba3483678366af49ac.

---

<a id="pubmed-pmid-19882898-selank-v1"></a>

## \[Antiviral activity of immunomodulator Selank in experimental influenza infection\].

> PubMed lists PMID 19882898 in Voprosy virusologii as Journal Article, with publication-date metadata of 2009 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-19882898-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-17
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-19882898-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-19882898-selank-v1
- Content SHA-256: `2738749c08fc4700877641e31b0c2cd0fd3e0a97c05445b26fe846aff62ec0d1`

### Claims and source pins

#### Headline

\[Antiviral activity of immunomodulator Selank in experimental influenza infection\]. ([`pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845`](#source-pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845))

#### Summary

PubMed lists PMID 19882898 in Voprosy virusologii as Journal Article, with publication-date metadata of 2009 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845`](#source-pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845))

#### Paragraph 1

PubMed lists PMID 19882898 in Voprosy virusologii as Journal Article, with publication-date metadata of 2009 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845`](#source-pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845`](#source-pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845))

### Sources

<a id="source-pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845"></a>
- **\[Antiviral activity of immunomodulator Selank in experimental influenza infection\]. · retained source version 1:2018-12-17:current:ecd4c61458451cf7662a10903283bc799744e0836821828adb68ea8a9bc8979f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/19882898/) (`pubmed-observation-pmid-19882898-2018-12-17-ecd4c6145845`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Antiviral activity of immunomodulator Selank in experimental influenza infection\]." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-19882898-selank-v1 SHA-256: 2738749c08fc4700877641e31b0c2cd0fd3e0a97c05445b26fe846aff62ec0d1.

---

<a id="pubmed-pmid-20506839-selank-v1"></a>

## Antiviral properties of structural fragments of the peptide Selank.

> PubMed lists PMID 20506839 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-20506839-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-16
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20506839-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-20506839-selank-v1
- Content SHA-256: `ab70926d7e50bccf3a75ff4cfa54f076d20574995f0de317477aa20cc500cb8f`

### Claims and source pins

#### Headline

Antiviral properties of structural fragments of the peptide Selank. ([`pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3`](#source-pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3))

#### Summary

PubMed lists PMID 20506839 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3`](#source-pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3))

#### Paragraph 1

PubMed lists PMID 20506839 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010 Mar-Apr (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3`](#source-pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3`](#source-pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3))

### Sources

<a id="source-pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3"></a>
- **Antiviral properties of structural fragments of the peptide Selank. · retained source version 1:2026-10-16:current:8ffb138959a33d4e41a86da53fa13a876c3b81f7bca7f1c49356caacfb3707f3** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20506839/) (`pubmed-observation-pmid-20506839-2026-10-16-8ffb138959a3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Antiviral properties of structural fragments of the peptide Selank." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-20506839-selank-v1 SHA-256: ab70926d7e50bccf3a75ff4cfa54f076d20574995f0de317477aa20cc500cb8f.

---

<a id="pubmed-pmid-20919548-selank-v1"></a>

## \[Experimental optimization of learning and memory processes by selank\].

> PubMed lists PMID 20919548 in Eksperimental'naia i klinicheskaia farmakologiia as Journal Article, with publication-date metadata of 2010-08 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-20919548-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-17
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-20919548-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-20919548-selank-v1
- Content SHA-256: `638ed1ab4d7e14e67f265b5e6a2950b21b636271b9be9898ed451fef19d0b9e8`

### Claims and source pins

#### Headline

\[Experimental optimization of learning and memory processes by selank\]. ([`pubmed-observation-pmid-20919548-2018-12-17-149691f15004`](#source-pubmed-observation-pmid-20919548-2018-12-17-149691f15004))

#### Summary

PubMed lists PMID 20919548 in Eksperimental'naia i klinicheskaia farmakologiia as Journal Article, with publication-date metadata of 2010-08 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20919548-2018-12-17-149691f15004`](#source-pubmed-observation-pmid-20919548-2018-12-17-149691f15004))

#### Paragraph 1

PubMed lists PMID 20919548 in Eksperimental'naia i klinicheskaia farmakologiia as Journal Article, with publication-date metadata of 2010-08 (month precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-20919548-2018-12-17-149691f15004`](#source-pubmed-observation-pmid-20919548-2018-12-17-149691f15004))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-20919548-2018-12-17-149691f15004`](#source-pubmed-observation-pmid-20919548-2018-12-17-149691f15004))

### Sources

<a id="source-pubmed-observation-pmid-20919548-2018-12-17-149691f15004"></a>
- **\[Experimental optimization of learning and memory processes by selank\]. · retained source version 1:2018-12-17:current:149691f15004bb6ceb48792cb6bbbe66b4ac775a2d53a2e73cebdd61683e5c91** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/20919548/) (`pubmed-observation-pmid-20919548-2018-12-17-149691f15004`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Experimental optimization of learning and memory processes by selank\]." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-20919548-selank-v1 SHA-256: 638ed1ab4d7e14e67f265b5e6a2950b21b636271b9be9898ed451fef19d0b9e8.

---

<a id="pubmed-pmid-21609736-selank-v1"></a>

## Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank.

> PubMed lists PMID 21609736 in Regulatory peptides as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-05-24 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-21609736-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-17
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-21609736-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-21609736-selank-v1
- Content SHA-256: `d30c0ce1586eaf2b65bed31cf2f3851d0fb66bd156560780c8b4b880dbd3d5f7`

### Claims and source pins

#### Headline

Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. ([`pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39`](#source-pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39))

#### Summary

PubMed lists PMID 21609736 in Regulatory peptides as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-05-24 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39`](#source-pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39))

#### Paragraph 1

PubMed lists PMID 21609736 in Regulatory peptides as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2011-05-24 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39`](#source-pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39`](#source-pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39))

### Sources

<a id="source-pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39"></a>
- **Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank. · retained source version 1:2018-12-17:current:c0512bacfa3997242787997946759462773d6324dd424014b5d0c4757a78db6f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/21609736/) (`pubmed-observation-pmid-21609736-2018-12-17-c0512bacfa39`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Expression of inflammation-related genes in mouse spleen under tuftsin analog Selank." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-21609736-selank-v1 SHA-256: d30c0ce1586eaf2b65bed31cf2f3851d0fb66bd156560780c8b4b880dbd3d5f7.

---

<a id="pubmed-pmid-24450168-selank-v1"></a>

## \[Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank\].

> PubMed lists PMID 24450168 in Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova as Journal Article, with publication-date metadata of 2013 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24450168-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-11-12
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24450168-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-24450168-selank-v1
- Content SHA-256: `60e230a4e266097d5f0d4a133f0c10edcc5e65c2f1ba063e5f9e7a2061cfae41`

### Claims and source pins

#### Headline

\[Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank\]. ([`pubmed-observation-pmid-24450168-2019-11-12-5d915deff760`](#source-pubmed-observation-pmid-24450168-2019-11-12-5d915deff760))

#### Summary

PubMed lists PMID 24450168 in Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova as Journal Article, with publication-date metadata of 2013 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24450168-2019-11-12-5d915deff760`](#source-pubmed-observation-pmid-24450168-2019-11-12-5d915deff760))

#### Paragraph 1

PubMed lists PMID 24450168 in Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova as Journal Article, with publication-date metadata of 2013 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24450168-2019-11-12-5d915deff760`](#source-pubmed-observation-pmid-24450168-2019-11-12-5d915deff760))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24450168-2019-11-12-5d915deff760`](#source-pubmed-observation-pmid-24450168-2019-11-12-5d915deff760))

### Sources

<a id="source-pubmed-observation-pmid-24450168-2019-11-12-5d915deff760"></a>
- **\[Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank\]. · retained source version 1:2019-11-12:current:5d915deff760128abda3848a090dc64dd9266b0948745a1acbedc5eff2e9ae63** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24450168/) (`pubmed-observation-pmid-24450168-2019-11-12-5d915deff760`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Transcriptome alteration in hippocampus under the treatment of tuftsin analog Selank\]." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-24450168-selank-v1 SHA-256: 60e230a4e266097d5f0d4a133f0c10edcc5e65c2f1ba063e5f9e7a2061cfae41.

---

<a id="pubmed-pmid-25371249-selank-v1"></a>

## The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome.

> PubMed lists PMID 25371249 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, with publication-date metadata of 2014-11-05 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-25371249-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-10-11
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-25371249-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-25371249-selank-v1
- Content SHA-256: `cdf689147da066aab67a1a766f71c891ac6a0a66edc79fc97bce6a10d3a3a132`

### Claims and source pins

#### Headline

The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome. ([`pubmed-observation-pmid-25371249-2026-10-11-265bef19e940`](#source-pubmed-observation-pmid-25371249-2026-10-11-265bef19e940))

#### Summary

PubMed lists PMID 25371249 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, with publication-date metadata of 2014-11-05 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25371249-2026-10-11-265bef19e940`](#source-pubmed-observation-pmid-25371249-2026-10-11-265bef19e940))

#### Paragraph 1

PubMed lists PMID 25371249 in Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections as Journal Article, with publication-date metadata of 2014-11-05 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-25371249-2026-10-11-265bef19e940`](#source-pubmed-observation-pmid-25371249-2026-10-11-265bef19e940))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-25371249-2026-10-11-265bef19e940`](#source-pubmed-observation-pmid-25371249-2026-10-11-265bef19e940))

### Sources

<a id="source-pubmed-observation-pmid-25371249-2026-10-11-265bef19e940"></a>
- **The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome. · retained source version 1:2026-10-11:current:265bef19e94056f2a7d31a5930d833325e9b911b1dc600e931822f59132f9353** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/25371249/) (`pubmed-observation-pmid-25371249-2026-10-11-265bef19e940`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-25371249-selank-v1 SHA-256: cdf689147da066aab67a1a766f71c891ac6a0a66edc79fc97bce6a10d3a3a132.

---

<a id="pubmed-pmid-26356395-selank-v1"></a>

## \[Optimization of the treatment of anxiety disorders with selank\].

> PubMed lists PMID 26356395 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2015 (year precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-26356395-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2018-12-17
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-26356395-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-26356395-selank-v1
- Content SHA-256: `d42b5f2822dcd865157637efc257635bf17a4ad71800dde920f0c91c3f7aae75`

### Claims and source pins

#### Headline

\[Optimization of the treatment of anxiety disorders with selank\]. ([`pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d`](#source-pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d))

#### Summary

PubMed lists PMID 26356395 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2015 (year precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d`](#source-pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d))

#### Paragraph 1

PubMed lists PMID 26356395 in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2015 (year precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d`](#source-pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d`](#source-pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d))

### Sources

<a id="source-pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d"></a>
- **\[Optimization of the treatment of anxiety disorders with selank\]. · retained source version 1:2018-12-17:current:2793cb613a2d9e10156bc8a73c0208493564e1a5e0dad329570d64a7cb77f68d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/26356395/) (`pubmed-observation-pmid-26356395-2018-12-17-2793cb613a2d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "\[Optimization of the treatment of anxiety disorders with selank\]." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-26356395-selank-v1 SHA-256: d42b5f2822dcd865157637efc257635bf17a4ad71800dde920f0c91c3f7aae75.

---

<a id="pubmed-pmid-28293190-selank-v1"></a>

## GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells.

> PubMed lists PMID 28293190 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2017-02-28 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-28293190-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2020-09-29
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28293190-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-28293190-selank-v1
- Content SHA-256: `ebe38ba4feaedd01f372d648d655627b06e0f58f4492d8e2037cdc21fdff999f`

### Claims and source pins

#### Headline

GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. ([`pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad`](#source-pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad))

#### Summary

PubMed lists PMID 28293190 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2017-02-28 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad`](#source-pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad))

#### Paragraph 1

PubMed lists PMID 28293190 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2017-02-28 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad`](#source-pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad`](#source-pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad))

### Sources

<a id="source-pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad"></a>
- **GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells. · retained source version 1:2020-09-29:current:e029b9f062ad8266dec7d69cfdf2d68fa4e5d1eb93aa8da86d5fb9a249b6a2b1** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28293190/) (`pubmed-observation-pmid-28293190-2020-09-29-e029b9f062ad`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 Cells." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-28293190-selank-v1 SHA-256: ebe38ba4feaedd01f372d648d655627b06e0f58f4492d8e2037cdc21fdff999f.

---

<a id="pubmed-pmid-30255741-selank-v1"></a>

## Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity.

> PubMed lists PMID 30255741 in Protein and peptide letters as Journal Article, with publication-date metadata of 2018 (year precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-30255741-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-01-07
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-30255741-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-30255741-selank-v1
- Content SHA-256: `9d9862ad324cf973db28dcebc9d4c88d921888dc00861e1a100ae0f83b1e5434`

### Claims and source pins

#### Headline

Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. ([`pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066`](#source-pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066))

#### Summary

PubMed lists PMID 30255741 in Protein and peptide letters as Journal Article, with publication-date metadata of 2018 (year precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066`](#source-pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066))

#### Paragraph 1

PubMed lists PMID 30255741 in Protein and peptide letters as Journal Article, with publication-date metadata of 2018 (year precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066`](#source-pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066`](#source-pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066))

### Sources

<a id="source-pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066"></a>
- **Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity. · retained source version 1:2019-01-07:current:4769fdbd4066ec100c50053ffa5c1a521dee21cebaa0963b45a72c157d33578e** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/30255741/) (`pubmed-observation-pmid-30255741-2019-01-07-4769fdbd4066`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Peptide-based Anxiolytics: The Molecular Aspects of Heptapeptide Selank Biological Activity." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-30255741-selank-v1 SHA-256: 9d9862ad324cf973db28dcebc9d4c88d921888dc00861e1a100ae0f83b1e5434.

---

<a id="pubmed-pmid-31236882-selank-v1"></a>

## State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment.

> PubMed lists PMID 31236882 in Bulletin of experimental biology and medicine as Journal Article, with publication-date metadata of 2019-06-24 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-31236882-selank:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-12-17
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-31236882-selank/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-31236882-selank-v1
- Content SHA-256: `8d87b36540c60586116811304810f16f85528c147b592297be8d7cf2cbb279dc`

### Claims and source pins

#### Headline

State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment. ([`pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3`](#source-pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3))

#### Summary

PubMed lists PMID 31236882 in Bulletin of experimental biology and medicine as Journal Article, with publication-date metadata of 2019-06-24 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3`](#source-pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3))

#### Paragraph 1

PubMed lists PMID 31236882 in Bulletin of experimental biology and medicine as Journal Article, with publication-date metadata of 2019-06-24 (day precision). PeptideScanner associated the retained record with the identity slug selank. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3`](#source-pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3`](#source-pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3))

### Sources

<a id="source-pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3"></a>
- **State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment. · retained source version 1:2019-12-17:current:924a8c8075c3a3c69fc8c66dc57e0ba43c10ae5579a11e7d866e5d2d9c7ec85d** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/31236882/) (`pubmed-observation-pmid-31236882-2019-12-17-924a8c8075c3`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/selank.json#pubmed-pmid-31236882-selank-v1 SHA-256: 8d87b36540c60586116811304810f16f85528c147b592297be8d7cf2cbb279dc.

